InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by William Arsani, 董事. Director active across 1 company, notably Design Therapeutics, Inc.. Aggregated, 6 filings have been recorded. Breakdown: 3 buys · 2 sells. Total volume traded: €6.2m. Activity tracked since 31 August 2021. The latest transaction was disclosed on 13 August 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
William Arsani is a Board Member at Design Therapeutics, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. William brings his expertise to guide the direction of Design Therapeutics and ensure compliance with governance standards. His commitment to operational excellence is a valuable asset to the board.